Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Melanoma and related topics: MedlinePlus Genetics were added to the page's topic metadata, and the revision note updated from v3.5.3 to v3.5.4. This update serves as metadata/versioning information rather than a change to core content.
    Difference
    0.2%
    Check dated 2026-05-15T05:43:34.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added under Related topics, expanding the page with additional disease context and genetics resources for users.
    Difference
    0.2%
    Check dated 2026-05-08T10:27:36.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now reflects an updated ClinicalTrials.gov interface revision (v3.5.3) and the related generic topic/link section text was refreshed (with “Melanoma”/“related topics” and a prior revision reference removed). This represents a platform/content wrapper update rather than a change to the study record itself.
    Difference
    0.2%
    Check dated 2026-04-24T06:01:47.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added Melanoma and MedlinePlus Genetics as related topics; updated page revision from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-17T02:35:10.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Melanoma-related topics and the MedlinePlus Genetics related links were removed from the page's related topics section.
    Difference
    0.2%
    Check dated 2026-03-26T11:19:11.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added Melanoma and related topics, including MedlinePlus Genetics, and updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T21:19:52.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.